A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
Clinical trial NCT04133636 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04133636
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-07
- Primary completion
- 2027-02-26
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.